Skip to main content

Table 2 Predefined list of select therapies included in the meta-analysis

From: Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis

Class

Example of therapies

Interleukins

IL-10, IL-2

Cell therapy

MSCs, MSC-derived microvesicles

Adrenergic beta-agonists

Salbutamol, albuterol, sultanol, proventil

Growing factors

Fibroblast growing factors, keratinocyte growth factor, endothelial growth factor

RAGE modulators

Anti-RAGE antibody, recombinant soluble RAGE, gene knockout, endogenous secretory RAGE

Corticosteroids

Glucocorticoids, mineralocorticoids, 3-oxo steroid, 17-ketosteroids, domolene, cortifan, epicortisol, komed-hc, heb-cort, prednisone, encortone, panasol, deltacortisone, decortisyl, decortin, predeltin, orasone, prednidib, prednisone, dacortin, cortancyl, solupred, deltasone, pronisone, sterapred, encorton, panafcort, delta-dome, dehydrocortisone, prednisonum, lisacort, ultracorten, winpred, metacortandracin, meticorten, prednisolone, predate, prednisolone, di-adreson f, delta-1-hydrocortisone, prednisolonum, sterane, meti derm, metacortandralone, predonine

Anticoagulant agents

Heparin, antithrombin, plasminogen activator, fibrinolytic agents, tissue factor pathway inhibitor, lipoprotein-associated coagulation inhibitor, thrombin-thrombomodulin complex, thrombin receptor, activated protein C, drotrecogin alfa activated

Halogenated agents

Sevoflurane, desflurane, isoflurane

  1. IL interleukin; MSCs mesenchymal stem (stromal) cells; RAGE receptor for advanced glycation end-products